Name Dan Mendelson | ||
Dan Mendelson on the Trump Administration's Efforts to Lower Drug Prices
Dan Mendelson is an American businessman and healthcare consultant who serves as chief executive officer of Avalere Health, a Washington, D.C.-based strategic advisory company. His opinions have been cited in The New York Times,The Wall Street Journal, National Public Radio, and Bloomberg, among other news outlets. He is the author of numerous papers and several editorials.
Contents
- Dan Mendelson on the Trump Administrations Efforts to Lower Drug Prices
- Early life and education
- Career
- Board memberships
- References
Mendelson is also a lecturer at the Fuqua School of Business at Duke University.
Early life and education
Mendelson was born in Fort Belvoir, Virginia and grew up in Bethesda, Maryland. He earned a B.A. from Oberlin College and a Masters of Public Policy from Harvard University’s John F. Kennedy School of Government.
Career
Mendelson began his career in health policy working for Professor William B. Schwartz at Tufts University, and co-authored a range of articles during that time. He next served as Senior Vice President of The Lewin Group and Director of its Medical Technology Practice.
Before founding Avalere, Mendelson served as associate director for health at the White House Office of Management and Budget]] during the Clinton administration. In this position, he was responsible for preparing the President’s health budget in consultation with other White House offices, managing the appropriations process with Members of Congress and their staffs and overseeing a range of management and budget issues in the U.S. Department of Health and Human Services, the United States Department of Veterans Affairs, and the Office of Personnel Management.
On leaving the White House in 2000, Mendelson founded The Health Strategies Consultancy, renamed Avalere Health in 2005. The company provides advisory services, research, and data products to a range of commercial and non-profit customers with interests in healthcare, providing oft-cited studies on Medicare, Medicaid, the 340B Drug Pricing Program, and the health insurance marketplace. In 2015 Mendelson sold Avalere to Inovalon Holdings to focus the efforts of the group on deployment of platforms to improve quality.
Board memberships
Mendelson serves on the board of directors of Champions Oncology. He previously served on the boards of Coventry Health Care, PharMerica, and HMS Holdings.